2018 Clinical Genomics Market By Test Type, Software, Method and End User - Global $879 Million Opportunity Analysis and Industry Forecast to 2023 - ResearchAndMarkets.com

DUBLIN--()--The "Clinical Genomics Market By Test Type, Software, Method and End User - Global Opportunity Analysis and Industry Forecast to 2023" report has been added to ResearchAndMarkets.com's offering

Global clinical genomics market is expected to reach USD 879.0 million by 2023, at a CAGR of 17.1% during the forecast period of 2018 to 2023.

The report carries out an impact analysis of the key industry drivers, restraints, opportunities, challenges, and trends in the global market.

The global clinical genomics market is mainly driven by growing significance of early disease detection and prevention, rising insistence for precision medicine, increasing application of genetic testing in oncology, and favourable reimbursement scenario related to genetic testing. However, high cost and social and ethical implications of genetic testing hinder the growth of clinical genomics market to some extent.

Scope of the Report:

Market by Test Type:

  • Diagnostic Testing
  • Genetic Testing
  • Newborn Screening
  • Preimplantation Testing
  • Prenatal Testing
  • Carrier Testing
  • Other Tests

Market by Method:

  • Molecular Tests
  • Chromosomal Tests
  • Biochemical Tests

Market by End User:

  • Hospitals & Clinics
  • Government Laboratories & Research Centres
  • Academics and Research Institutes
  • Other End Users

Companies Mentioned

  • 23andMe, Inc.
  • Beijing Genomics Institute (BGI)
  • CENTOGENE AG
  • Clinical Genomics Technologies Pty Ltd.
  • Eurofins Scientific SE
  • Foundation Medicine, Inc.
  • Gene by Gene Ltd
  • GenomeDx Biosciences, Inc.
  • Genomic Health, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Iverson Genetic Diagnostics, Inc.
  • MedGenome
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • NeoGenomics, Inc.
  • OPKO Health, Inc.
  • Pathgroup
  • PerkinElmer, Inc.
  • Personalis, Inc.
  • Quest Diagnostics Incorporated
  • Retrogen, Inc.
  • Rosetta Genomics, Ltd.
  • Strand Life Sciences Pvt. Ltd.
  • Veritas Genetics

For more information about this report visit https://www.researchandmarkets.com/research/mkhlcl/2018_clinical?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics